Head and Neck Neoplasms

"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Descriptor ID	D006258
MeSH Number(s)	C04.588.443
Concept/Terms	Head and Neck Neoplasms Head and Neck Neoplasms Neoplasms, Head and Neck Head, Neck Neoplasms Cancer of Head and Neck Cancer of Head and Neck Head and Neck Cancer Cancer of the Head and Neck Upper Aerodigestive Tract Neoplasms Upper Aerodigestive Tract Neoplasms UADT Neoplasms Neoplasm, UADT Neoplasms, UADT UADT Neoplasm Neoplasms, Upper Aerodigestive Tract Head Neoplasms Head Neoplasms Neoplasms, Head Neck Neoplasms Neck Neoplasms Neoplasms, Neck Cancer of Head Cancer of Head Head Cancer Cancer of the Head Cancer of Neck Cancer of Neck Neck Cancer Cancer of the Neck

Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Head and Neck Neoplasms [C04.588.443]

Below are MeSH descriptors whose meaning is related to "Head and Neck Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.

Bar chart showing 142 publications over 25 distinct years, with a maximum of 16 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2000	1	0	1
2002	5	1	6
2003	2	0	2
2004	4	0	4
2005	5	0	5
2006	2	1	3
2007	6	1	7
2008	7	0	7
2009	3	0	3
2010	3	2	5
2011	7	1	8
2012	7	0	7
2013	13	3	16
2014	7	0	7
2015	6	1	7
2016	9	1	10
2017	8	1	9
2018	4	0	4
2019	4	0	4
2020	6	2	8
2021	6	0	6
2022	8	0	8
2023	3	0	3
2024	0	1	1

Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.

Sweeny L, Konuthula N, Jackson R, Wax MK, Curry JM, Yang S, Amin D, Kane AC, Cannady SB, Tasche K, DiLeo M, Lander D, Kejner AE, Pipkorn P. Microvascular reconstruction of midface osteoradionecrosis. Head Neck. 2024 Nov; 46(11):2824-2833.

View in: PubMed
Ko EC, Hanna GJ. Immunotherapy for head and neck cancer: where do we go from here? Immunotherapy. 2023 12; 15(18):1497-1500.

View in: PubMed
Zhang X, Ilyas OS, Getz KR, Rozek LS, Taylor JMG, Chinn SB, Wolf GT, Mondul AM. Aspirin use and head and neck cancer survival and recurrence. Cancer Causes Control. 2024 Apr; 35(4):605-609.

View in: PubMed
Cousseau CPV, Sorroche BP, de Jesus Teixeira R, de Carvalho AC, Melendez ME, de Castro Capuzzo R, Laus AC, da Silva LS, de Menezes NS, Carvalho AL, Arantes LMRB. miR-99a-5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients. Head Neck. 2023 10; 45(10):2489-2497.

View in: PubMed
Perez-Pacheco C, Schmitd LB, Furgal A, Bellile EL, Liu M, Fattah A, Gonzalez-Maldonado L, Unsworth SP, Wong SY, Rozek LS, Rao A, Wolf GT, Taylor JMG, Casper K, Mierzwa M, D'Silva NJ. Increased Nerve Density Adversely Affects Outcome in Oral Cancer. Clin Cancer Res. 2023 07 05; 29(13):2501-2512.

View in: PubMed
Tanagala KKK, Morin-Baxter J, Carvajal R, Cheema M, Dubey S, Nakagawa H, Yoon A, Cheng YL, Taylor A, Nickerson J, Mintz A, Momen-Heravi F. SP140 inhibits STAT1 signaling, induces IFN-? in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. J Immunother Cancer. 2022 12; 10(12).

View in: PubMed
Crist M, Yaniv B, Palackdharry S, Lehn MA, Medvedovic M, Stone T, Gulati S, Karivedu V, Borchers M, Fuhrman B, Crago A, Curry J, Martinez-Outschoorn U, Takiar V, Wise-Draper TM. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. J Immunother Cancer. 2022 11; 10(11).

View in: PubMed
Smith JD, Bellile EL, Ellsperman SE, Heft-Neal ME, Mann JE, Birkeland AC, Hoesli RC, Swiecicki PL, Worden FP, Schonewolf C, Shah JL, Mierzwa ML, Rosko AJ, Stucken CL, Chinn SB, Shuman AG, Casper KA, Malloy KM, Prince MEP, Wolf GT, Thomas DG, McHugh JB, Chad Brenner J, Spector ME. Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma. Oral Oncol. 2022 12; 135:106226.

View in: PubMed
Schmitd LB, Perez-Pacheco C, Bellile EL, Wu W, Casper K, Mierzwa M, Rozek LS, Wolf GT, Taylor JMG, D'Silva NJ. Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer. Clin Cancer Res. 2022 08 15; 28(16):3557-3572.

View in: PubMed
Konuthula N, Do OA, Gobillot T, Rodriguez CP, Futran ND, Houlton J, Barber BR. Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study. Head Neck. 2022 11; 44(11):2465-2472.

View in: PubMed

People

Explore

Similar Concepts

Top Journals